Biotech/Biomedical
News Category

CAC Testing Positioned as Targeted Decision Aid, Not Universal Screening Tool
The American Heart Association clarifies that coronary artery calcium testing is best used as a targeted decision aid for people at borderline or inte...

NanoViricides Advances NV-387 into Phase 2 Trials for Ebola and Mpox, Eyes Measles with FDA Designations
NanoViricides has initiated two Phase 2 clinical trials for its broad-spectrum antiviral NV-387 in Ebola and mpox, while leveraging FDA designations t...

Wrap Technologies Q3 Revenue Holds Steady as Nine-Month Growth and ATF Ruling Signal Strategic Progress
Wrap Technologies reported flat third-quarter revenue but 43% nine-month growth and a key ATF classification for its BolaWrap 150, highlighting its po...

Waterhouse Brands Appoints Tom Haan as Chief Brand Strategist, Integrates 22 Fillmore
Waterhouse Brands has named Tom Haan as Chief Brand Strategist and integrated his firm, 22 Fillmore, to deepen its life sciences branding expertise as...

Nutriband's USPTO Allowance for Fentanyl Patch Brand Names Signals Progress Toward Market Launch
Nutriband Inc. received a USPTO Notice of Allowance for brand names tied to its abuse-deterrent fentanyl patch, advancing regulatory and commercial pr...

Sino Biological Launches AI-Trusted and AI-Qualified Protein Collections to Validate AI-Designed Molecules
Sino Biological introduces two curated target protein collections, AI-Trusted and AI-Qualified, providing experimentally characterized proteins essent...

Gold Slips Below $4,000 as Dollar Strength and Fed Repricing Pressure Bullion
Gold's drop below the $4,000 mark reflects a firmer U.S. dollar and shifting Federal Reserve rate expectations, with implications for miners like Coll...

Patients Trust AI in Healthcare More Than Doctors Do, Survey Finds
A new Gallup and West Health survey reveals a stark contrast between patients' comfort with AI-assisted healthcare and doctors' skepticism, raising qu...

Moody’s 2027 Bank Outlook Signals Strength, But Challenges for Big Holders Like Berkshire Hathaway
Moody’s outlook for 2027 highlights strong global banks, but this strength complicates forecasting for major bank investors such as Berkshire Hathaway...

Cardio Diagnostics Schedules Dec. 10 Investor Call to Detail FDA Breakthrough Device Plans and NOCAD Detection Strategy
Cardio Diagnostics Holdings will host a Dec. 10 investor call to outline its FDA Breakthrough Device designation strategy, non-obstructive coronary ar...

VolitionRx Expands Fujifilm Vet Systems Agreement to Develop Feline Cancer Test in Japan
VolitionRx's expanded agreement with Fujifilm Vet Systems to develop a feline cancer test in Japan opens a potential revenue stream in a market with n...

Researcher David LaPoint Brings Healing Technology and Free-Energy Claims to Making Life Brighter Radio
David LaPoint's appearance on Making Life Brighter Radio highlights his sound, wave, and light energy research and its implications for healing techno...

iPSC Neural Models Offer Disease-Relevant Alternatives for Early Drug Discovery
Creative Biolabs is promoting complementary iPSC differentiation, neural model, and microfluidic culture solutions to help researchers select laborato...

MOCCI-Driven Metabolic Reprogramming Emerges as Key Driver of Lymph Node Metastasis in Lung Cancer
A new study reveals that MOCCI-driven oxidative phosphorylation reprogramming promotes lymph node metastasis in lung cancer by inducing Tfh cell exhau...

Viromed Medical AG Restructures Management Board to Drive Next Growth Phase
Viromed Medical AG appoints Christian Strauch to its Management Board as founder Uwe Perbandt resigns, signaling a strategic shift to capitalize on th...

Quantum BioPharma's $12.22M Cash and Digital Assets Fuel Lucid-MS Phase 2 Trial
Quantum BioPharma reported $12.22 million in cash and digital assets and advancing its Lucid-MS Phase 2 trial, signaling improved financial health and...

MindBio's AI Voice Tech Hits 83% Intoxication Detection Accuracy, Eyes Commercial Pilot
MindBio Therapeutics reports up to 83% accuracy in AI-driven voice intoxication detection, surpassing some cheek swab tests, and announces a $350,000 ...

CNS Pharmaceuticals Reports Q3 2026 Financials and Advances Pipeline Expansion Strategy
CNS Pharmaceuticals reported a narrowed Q3 2026 net loss and a strengthened cash position, while advancing discussions to acquire or license new thera...

Helus Pharma's Q2 Results Highlight Phase 3 Progress and Pipeline Expansion
Helus Pharma reported a wider net loss but completed enrollment in its pivotal Phase 3 trial for HLP003, signaling progress toward addressing major de...

Personalized Vaccines Extend Survival in Brain Cancer, Signaling New Era in Treatment
Personalized vaccines are showing promise in extending survival for glioblastoma patients, with UCLA's trial results offering hope and prompting broad...

Quantum Computing's Slow Path to the Pharmacy
Quantum computing could reshape drug discovery by solving complex molecular problems, but technical hurdles mean practical adoption remains years away...

Helus Pharma's Phase 3 Success for HLP003 in MDD Signals Potential New Treatment Option
Helus Pharma's positive Phase 3 results for HLP003 in major depressive disorder demonstrate statistically significant and rapid improvements, potentia...

American Heart Association Launches National Initiative to Close Lipid Management Gaps in Clinical Practice
The American Heart Association's new IMPLEMENT-Lipid Management initiative brings together 10 healthcare organizations to test and share practical str...

Wolfson Group to Launch Good Salt Hydration Brand in U.S. as Everyday Electrolyte Demand Surges
Wolfson Group plans to bring Good Salt, a functional hydration brand with day-part formulations, to the U.S., capitalizing on a 63% rise in electrolyt...

NOVA Medical Launches Surgeon-Guided Commercialization Model for Tissue Repair
NOVA Medical's formation introduces a collaborative, surgeon-led approach to bringing tissue repair technologies to market, potentially reshaping how ...

COPD Flare-Ups: Why Recognizing Inadequate Control Matters
People with COPD who experience persistent flare-ups despite treatment may have inadequately controlled disease, and a new treatment option could help...

Grand Mirrors Achieves UL Recognition, Bolstering Safety Credentials for Illuminated Mirrors
Grand Mirrors, Evervue's premium illuminated mirror brand, has earned UL Recognition (RU) under File Number E552871, reinforcing its commitment to qua...

SS Innovations Promotes Srivastava to President, Names Lo CFO as It Targets U.S. and EU Markets
The leadership changes at SS Innovations signal a strategic push to commercialize the SSi Mantra robotic surgery system in the U.S. and Europe while n...

Annovis Bio Sets March 2027 Readout for Phase 3 Alzheimer’s Trial, Bolstered by $21 Million Financing
Annovis Bio's Q3 2026 update highlights full enrollment of its Phase 3 Alzheimer's trial and a planned March 2027 data readout, with new financing exp...

Vycor Medical Posts Mixed Q3 2026 Results as VBAS Clinical Evidence Mounts
Vycor Medical's Q3 2026 revenue fell 19% on tough prior-year comparisons, but continued operating profitability and four new peer-reviewed VBAS studie...

Quantum BioPharma's $12.22 Million in Cash and Digital Assets Fuels Lucid-MS Phase 2 Trial
Quantum BioPharma's Q3 2026 results show $12.22 million in cash and digital assets, a 91% equity increase, and a key Phase 2 trial agreement for Lucid...

OptimumBank's 67% EPS Jump Signals Strengthening Growth and Profitability
OptimumBank Holdings reported a 67% year-over-year increase in third-quarter diluted earnings per share, driven by loan and deposit growth and improve...

Oragenics Secures NYSE American Listing Extension Through 2028
Oragenics receives a compliance extension from NYSE American through February 2028, allowing the clinical-stage biopharmaceutical company to maintain ...

Sino Biological Launches 4RISE™ to Speed AI-Designed Binder Validation
Sino Biological's 4RISE™ high-throughput wet-lab services aim to bridge the gap between AI-driven protein design and experimental validation, offering...

AI Cuts Echocardiogram Interpretation Time by Half, Boosting Cardiology Efficiency
Artificial intelligence can halve the time cardiologists spend interpreting heart scans while matching human accuracy, a development that could ease w...

Wastewater Study in Ohio Reveals Community Health Clues, Opening Door to Proactive Monitoring
A recent Ohio study found that wastewater can provide vital clues about community health patterns, enabling proactive measures and offering a readily ...

Redwood AI Adds Chemical Risk Evaluator to Reactosphere Platform
Redwood AI's new CARE feature integrates safety screening into its Reactosphere synthesis platform, enabling chemists to identify and mitigate risks e...

HeartBeam Cuts Q3 Loss as FDA Breakthrough Nod Sharpens Heart Attack Strategy
HeartBeam narrowed its third-quarter net loss to $3 million and advanced its heart attack assessment program with FDA Breakthrough Device Designation,...

SS Innovations Promotes Dr. Vishwa Srivastava to President, Appoints Gary Lo as CFO to Drive Global Expansion
SS Innovations International (NASDAQ: SSII) has promoted Dr. Vishwa Srivastava to president and appointed Gary Lo as CFO, strengthening its leadership...

Creative Biolabs Pairs AI Antibody Design with Developability Checks to Guide Go/No-Go Decisions
Creative Biolabs is integrating AI-driven antibody design and optimization with early developability assessment to help biopharma teams prioritize can...

SNIP Brings Physical AI Medical Robotics to MEDICA 2026 for Global Market Entry
The Seongnam Industry Promotion Agency (SNIP) is leading a delegation of Physical AI medical robotics companies to MEDICA 2026 to secure international...

Novogenia to Supply DNA Analytics and Personalized Supplements for GLP-1 Clinical Study in Abu Dhabi
Novogenia AG will conduct DNA analyses and manufacture personalized dietary supplements for a planned 500-participant clinical study in Abu Dhabi, aim...

Earth Science Tech's Vertical Integration Strategy Drives 57% Net Income Growth
Earth Science Tech Inc. is leveraging a vertically integrated business model to drive growth and profitability, as evidenced by its fiscal first-quart...

Cardio Diagnostics Whitepaper Highlights Diagnostic Gaps in Non-Obstructive Coronary Artery Disease
Cardio Diagnostics Holdings released a whitepaper on non-obstructive coronary artery disease, emphasizing the limitations of invasive angiography and ...

Immunotherapy Eliminates Brain Tumors in Preclinical Study, Human Trials Planned
A new immunotherapy wiped out all tumor cells in mice with brain tumors, prompting researchers to accelerate human trials, which could begin as early ...

NextPlat Cuts Q3 Net Loss by 66% as Gross Margin Expands to 35%
NextPlat Corp. reported a 66% reduction in its third-quarter net loss and a significant gross margin expansion, driven by growth in higher-margin phar...

